Literature DB >> 17599729

Progressive multifocal leukoencephalopathy in rheumatic diseases: evolving clinical and pathologic patterns of disease.

Leonard H Calabrese1, Eamonn S Molloy, DeRen Huang, Richard M Ransohoff.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17599729     DOI: 10.1002/art.22657

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  51 in total

1.  Incidence and risk factors for progressive multifocal leukoencephalopathy among patients with selected rheumatic diseases.

Authors:  A Bharat; F Xie; J W Baddley; T Beukelman; L Chen; L Calabrese; E Delzell; C G Grijalva; N M Patkar; K Saag; K L Winthrop; J R Curtis
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-04       Impact factor: 4.794

Review 2.  Does rituximab increase the incidence of infectious complications? A narrative review.

Authors:  Theodoros Kelesidis; George Daikos; Dimitrios Boumpas; Sotirios Tsiodras
Journal:  Int J Infect Dis       Date:  2010-11-11       Impact factor: 3.623

Review 3.  Gene-expression profiling in rheumatic disease: tools and therapeutic potential.

Authors:  Jason W Bauer; Hatice Bilgic; Emily C Baechler
Journal:  Nat Rev Rheumatol       Date:  2009-05       Impact factor: 20.543

4.  Therapy: Targeted but not trouble-free: efalizumab and PML.

Authors:  Eamonn S Molloy; Leonard H Calabrese
Journal:  Nat Rev Rheumatol       Date:  2009-08       Impact factor: 20.543

5.  Analysis of cerebrospinal fluid and cerebrospinal fluid cells from patients with multiple sclerosis for detection of JC virus DNA.

Authors:  E Iacobaeus; C Ryschkewitsch; M Gravell; M Khademi; E Wallstrom; T Olsson; L Brundin; Eo Major
Journal:  Mult Scler       Date:  2008-09-19       Impact factor: 6.312

Review 6.  Emerging viral infections of the central nervous system: part 2.

Authors:  Kenneth L Tyler
Journal:  Arch Neurol       Date:  2009-09

7.  Therapy: rituximab and PML risk-informed decisions needed!

Authors:  Leonard H Calabrese; Eamonn S Molloy
Journal:  Nat Rev Rheumatol       Date:  2009-10       Impact factor: 20.543

8.  JC virus infection of the brain.

Authors:  A K Bag; J K Curé; P R Chapman; G H Roberson; R Shah
Journal:  AJNR Am J Neuroradiol       Date:  2010-03-18       Impact factor: 3.825

Review 9.  [Translational aspects on the role of B-cells in autoimmune diseases. "From bench to bedside" and "from bed to benchside"].

Authors:  H Mei; T Dörner
Journal:  Z Rheumatol       Date:  2009-07       Impact factor: 1.372

10.  Rearrangement of the JC virus regulatory region sequence in the bone marrow of a patient with rheumatoid arthritis and progressive multifocal leukoencephalopathy.

Authors:  Angela Marzocchetti; Christian Wuthrich; Chen S Tan; Troy Tompkins; Francisco Bernal-Cano; Parul Bhargava; Allan H Ropper; Igor J Koralnik
Journal:  J Neurovirol       Date:  2008-11-06       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.